Signature | Real label | class | Prediction | sum | ||
---|---|---|---|---|---|---|
 |  |  | Benign ovarian tumour | BOT | Malignant ovarian tumour |  |
Clinic_Sig | Real label | Benign ovarian tumour | 98(89.91%) | 0(0%) | 11(10.09%) | 109 |
 |  | BOT | 11(100%) | 0(0%) | 0(0%) | 11 |
 |  | Malignant ovarian tumour | 41(83.67%) | 0(0%) | 8(16.33%) | 49 |
 |  | sum | 150 | 0 | 19 | 169 |
Rad_Sig | Real label | Benign ovarian tumour | 97(88.99%) | 0(0%) | 12(11.01%) | 109 |
 |  | BOT | 6(54.55%) | 0(0%) | 5(45.45%) | 11 |
 |  | Malignant ovarian tumour | 30(61.22%) | 0(0%) | 19(38.78%) | 49 |
 |  | sum | 133 | 0 | 36 | 169 |
DTL_Sig | Real label | Benign ovarian tumour | 94(86.24%) | 1(0.92%) | 14(12.84%) | 109 |
 |  | BOT | 4(36.36%) | 4(36.36%) | 3(27.28%) | 11 |
 |  | Malignant ovarian tumour | 14(28.58%) | 6(12.24%) | 29(59.18%) | 49 |
 |  | sum | 112 | 11 | 46 | 169 |
DRL_Sig | Real label | Benign ovarian tumour | 90(82.57%) | 2(1.83%) | 17(15.60%) | 109 |
 |  | BOT | 4(36.36%) | 6(54.55%) | 1(9.09%) | 11 |
 |  | Malignant ovarian tumour | 12(24.49%) | 6(12.24%) | 31(63.27%) | 49 |
 |  | sum | 106 | 14 | 49 | 169 |